• 1
    Kihara N, de la Fuente SG, Fujino K, Takahashi T, Pappas TN, Mantyh CR. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut 2003; 52: 7139.
  • 2
    Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Ann Rev Immunol 2002; 20: 495549.
  • 3
    Herbert MK, Holzer P. Neurogenic inflammation. I. Basic mechanisms, physiology and pharmacology. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 2002; 37: 31425.
  • 4
    Mantyh CR, Gates TS, Zimmerman RP et al. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A 1988; 85: 32359.
  • 5
    Di Sebastiano P, Grossi L, Di Mola FF et al. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 1999; 44: 43944.
  • 6
    Vrees MD, Pricolo VE, Potenti FM, Cao W. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg 2002; 137: 43945; discussion 445–6.
  • 7
    Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994; 267: G15165.
  • 8
    Al-Saffar A, Hellstrom PM. Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand J Gastroenterol 2001; 36: 48593.
  • 9
    Li M, Johnson CP, Adams MB, Sarna SK. Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol Gastrointest Liver Physiol 2002; 283: G54452.
  • 10
    Mayer EA, Raybould H, Koelbel C. Neuropeptides, inflammation, and motility. Dig Dis Sci 1988; 33: 71S7S.
  • 11
    Kachur JF, Keshavarzian A, Sundaresan R et al. Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa. Inflammation 1995; 19: 24559.
  • 12
    Blandizzi C, Fornai M, Colucci R et al. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 2003; 139: 30920.
  • 13
    Linden DR, Sharkey KA, Mawe GM. Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon. J Physiol 2003; 547: 589601.
  • 14
    Lecci A, Carini F, Tramontana M et al. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models. J Pharmacol Exp Ther 2001; 299: 24754.
  • 15
    Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol Int 1994; 44: 62434.
  • 16
    Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999; 398: 43641.
  • 17
    Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Ann Rev Neurosci 2001; 24: 487517.
  • 18
    Olah Z, Karai L, Iadarola MJ. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 2001; 276: 3116370.
  • 19
    Kollarik M, Undem BJ. Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig. J Physiol 2002; 543: 591600.
  • 20
    Smart D, Gunthorpe MJ, Jerman JC et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000; 129: 22730.
  • 21
    Zygmunt PM, Petersson J, Andersson DA et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 4527.
  • 22
    Jaggar SI, Scott HC, James IF, Rice AS. The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder. Pain 2001; 89: 22935.
  • 23
    Schicho R, Schemann M, Pabst MA, Holzer P, Lippe IT. Capsaicin-sensitive extrinsic afferents are involved in acid-induced activation of distinct myenteric neurons in the rat stomach. Neurogastroenterol Motil 2003; 15: 3344.
  • 24
    Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol 2002; 118: 11021.
  • 25
    Szallasi A, Szabo T, Biro T et al. Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1. Br J Pharmacol 1999; 128: 42834.
  • 26
    Cortright DN, Crandall M, Sanchez JF, Zou T, Krause JE, White G. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun 2001; 281: 11839.
  • 27
    Stenholm E, Bongenhielm U, Ahlquist M, Fried K. VRl- and VRL-l-like immunoreactivity in normal and injured trigeminal dental primary sensory neurons of the rat. Acta Odontol Scand 2002; 60: 729.
  • 28
    Tohda C, Sasaki M, Konemura T, Sasamura T, Itoh M, Kuraishi Y. Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 2001; 76: 162835.
  • 29
    Anavi-Goffer S, McKay NG, Ashford ML, Coutts AA. Vanilloid receptor type 1-immunoreactivity is expressed by intrinsic afferent neurones in the guinea-pig myenteric plexus. Neurosci Lett 2002; 319: 537.
  • 30
    Patterson LM, Zheng H, Ward SM, Berthoud HR. Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res 2003; 311: 27787.
  • 31
    Yiangou Y, Facer P, Dyer NH et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357: 13389.
  • 32
    McVey DC, Vigna SR. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides 2001; 22: 143946.
  • 33
    McVey DC, Schmid PC, Schmid HH, Vigna SR. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J Pharmacol Exp Ther 2003; 304: 71322.
  • 34
    Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease [erratum appears in Curr Opin Immunol 2000; 12: 226]. Curr Opin Immunol 1999; 11: 64856.
  • 35
    Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Lab Invest. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993; 69: 23849.
  • 36
    Diaz-Granados HK, Lu J, McKay DM. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am J Pathol 2000; 156: 216977.
  • 37
    Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterization of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 2408.
  • 38
    Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method of induction of reliable experimental acute and chronic colitis in mice. Gastroenterology 1990; 98: 694702.
  • 39
    Stevceva L, Pavli P, Husband AJ, Doe WF. The inflammatory infiltrate in the acute stage of the dextran sulphate sodium-induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin Pathol 2001; 1: 313.
  • 40
    Sancho R, Lucena C, Macho A et al. Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappaB activation and is a potent antiinflammatory compound in vivo. Eur J Immunol 2002; 32: 175363.
  • 41
    Wallace JL, McCafferty DM, Sharkey KA. Lack of beneficial effect of a tachykinin receptor antagonist in experimental colitis. Regul Pept 1998; 73: 95101.
  • 42
    Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 285: G20716.
  • 43
    Mang CF, Erbelding D, Kilbinger H. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br J Pharmacol 2001; 134: 1617.
  • 44
    Mantyh CR, Maggio JE, Mantyh PW, Vigna SR, Pappas TN. Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis. Dig Dis Sci 1996; 41: 61420.
  • 45
    Castagliuolo I, Keates AC, Qiu B et al. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 1997; 94: 478893.
  • 46
    Evangelista S, Paoli S, Giachetti A, Manzini S. Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways. Neuropeptides 1997; 31: 6570.
  • 47
    Quinlan KL, Song IS, Naik SM et al. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. J Immunol 1999; 162: 165661.
  • 48
    Nakagawa N, Sano H, Iwamoto I. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 1995; 16: 7215.
  • 49
    Kunkel SL, Strieter RM, Chensue SW et al. Tumor necrosis factor-alpha, interleukin-8 and chemotactic cytokines. Prog Clin Biol Res 1990; 349: 43344.
  • 50
    Goh J, Baird AW, O'Keane C et al. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J Immunol 2001; 167: 277280.
  • 51
    Beales IL, Calam J. Stimulation of IL-8 production in human gastric epithelial cells by Helicobacter pylori, IL-1beta and TNF-alpha requires tyrosine kinase activity, but not protein kinase C. Cytokine 1997; 9: 51420.
  • 52
    Amaya F, Oh-hashi K, Naruse Y et al. Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res 2003; 963: 1906.
  • 53
    Maggi CA, Borsini F, Santicioli P et al. Cutaneous lesions in capsaicin-pretreated rats. A trophic role of capsaicin-sensitive afferents? Naunyn Schmiedebergs Arch Pharmacol 1987; 336: 53845.
  • 54
    Renzi D, Evangelista S, Mantellini P et al. Capsaicin-induced release of neurokinin A from muscle and mucosa of gastric corpus: correlation with capsaicin-evoked release of calcitonin gene-related peptide. Neuropeptides 1991; 19: 13745.
  • 55
    Nozawa Y, Nishihara K, Yamamoto A, Nakano M, Ajioka H, Matsuura N. Distribution and characterization of vanilloid receptors in the rat stomach. Neurosci Lett 2001; 309: 336.
  • 56
    Stucchi AF, Shofer S, Leeman S et al. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol - Gastrointest Liver Physiol 2000; 279: G1298306.
  • 57
    Fujino K, de la Fuente SG, Pappas TN, Mantyh CR. Dextran sulfate sodium-induced enterocolitis is attenuated in vanilloid receptor-1 knock out mice. Gastroenterology 2003; 124: A300.